Cardiopulmonary arrest (CA) is a major cause of death/disability in the U.S. with poor prognosis and survival rates. Current therapeutic challenges are physiologically complex because they involve hypoperfusion (decreased cerebral blood flow), neuroinflammation, and mitochondrial dysfunction. We previously discovered novel serum/glucocorticoid-regulated kinase 1 (SGK1) is highly expressed in brain of neurons that are susceptible to ischemia (hippocampus and cortex). We inhibited SGK1 and utilized pharmacological (specific inhibitor, GSK650394) and neuron-specific genetic approaches (shRNA) in rodent models of CA to determine if SGK1 is responsible for hypoperfusion, neuroinflammation, mitochondrial dysfunctional, and neurological deficits after CA. Inhibition of SGK1 alleviated cortical hypoperfusion and neuroinflammation (via Iba1, GFAP, and cytokine array). Treatment with GSK650394 enhanced mitochondrial function (via Seahorse respirometry) in the hippocampus 3 and 7 days after CA. Neuronal injury (via MAP2, dMBP, and Golgi staining) in the hippocampus and cortex was observed 7 days after CA but ameliorated with SGK1-shRNA. Moreover, SGK1 mediated neuronal injury by regulating the Ndrg1-SOX10 axis. Finally, animals subjected to CA exhibited learning/memory, motor, and anxiety deficits after CA, whereas SGK1 inhibition via SGK1-shRNA improved neurocognitive function. The present study suggests the fundamental roles of SGK1 in brain circulation and neuronal survival/death in cerebral ischemia-related diseases.
ViraniSSAlonsoAAparicioHJ, et al.
Heart disease and stroke statistics-2021 update: a report from the American heart association. Circulation2021;
143: e254–e743.
2.
NeumarRWNolanJPAdrieC, et al.
Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the international liaison committee on resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation2008;
118: 2452–2483.
3.
HarukuniIBhardwajA.Mechanisms of brain injury after global cerebral ischemia. Neurol Clin2006;
24: 1–21.
4.
SabriMLassEMacdonaldRL.Early brain injury: a common mechanism in subarachnoid hemorrhage and global cerebral ischemia. Stroke Res Treat2013;
2013: 394036.
5.
LangFBohmerCPalmadaM, et al.
(Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev2006;
86: 1151–1178.
6.
LeeRHGramesMSWuCY, et al.
Upregulation of serum and glucocorticoid-regulated kinase 1 exacerbates brain injury and neurological deficits after cardiac arrest. Am J Physiol Heart Circ Physiol2020;
319: H1044–H1050.
7.
BohmerCPalmadaMKenngottC, et al.
Regulation of the epithelial calcium channel TRPV6 by the serum and glucocorticoid-inducible kinase isoforms SGK1 and SGK3. FEBS Lett2007;
581: 5586–5590.
8.
LangFHenkeGEmbarkHM, et al.
Regulation of channels by the serum and glucocorticoid-inducible kinase – implications for transport, excitability and cell proliferation. Cell Physiol Biochem2003;
13: 41–50.
9.
GrahammerFArtuncFSandulacheD, et al.
Renal function of gene-targeted mice lacking both SGK1 and SGK3. Am J Physiol Regul Integr Comp Physiol2006;
290: R945–950.
10.
ArtuncFEbrahimASiraskarB, et al.
Responses to diuretic treatment in gene-targeted mice lacking serum- and glucocorticoid-inducible kinase 1. Kidney Blood Press Res2009;
32: 119–127.
11.
HelmsMNYuLMalikB, et al.
Role of SGK1 in nitric oxide inhibition of ENaC in Na+-transporting epithelia. Am J Physiol Cell Physiol2005;
289: C717–726.
12.
AllistonTNGonzalez-RobaynaIJBuseP, et al.
Expression and localization of serum/glucocorticoid-induced kinase in the rat ovary: relation to follicular growth and differentiation. Endocrinology2000;
141: 385–395.
13.
Avishai-ElinerSYiSJBaramTZ.Developmental profile of messenger RNA for the corticotropin-releasing hormone receptor in the rat limbic system. Brain Res Dev Brain Res1996;
91: 159–163.
14.
BabanBLiuJYMozaffariMS.SGK-1 regulates inflammation and cell death in the ischemic-reperfused heart: pressure-related effects. Am J Hypertens2014;
27: 846–856.
15.
BelAibaRSDjordjevicTBonelloS, et al.
The serum- and glucocorticoid-inducible kinase sgk-1 is involved in pulmonary vascular remodeling: role in redox-sensitive regulation of tissue factor by thrombin. Circ Res2006;
98: 828–836.
16.
EylensteinASchmidtSGuS, et al.
Transcription factor NF-kappaB regulates expression of pore-forming Ca2+ channel unit, Orai1, and its activator, STIM1, to control Ca2+ entry and affect cellular functions. J Biol Chem2012;
287: 2719–2730.
17.
RusaiKProkaiASzebeniB, et al.
Gender differences in serum and glucocorticoid regulated kinase-1 (SGK-1) expression during renal ischemia/reperfusion injury. Cell Physiol Biochem2011;
27: 727–738.
18.
Guide for the Care and Use of Laboratory Animals. 8th ed. Washington, DC: The National Academies Press, 2011.
19.
LeeRHCoutoESALernerFM, et al.
Interruption of perivascular sympathetic nerves of cerebral arteries offers neuroprotection against ischemia. Am J Physiol Heart Circ Physiol2017;
312: H182–H188.
20.
LeeRHCoutoESAPossoitHE, et al.
Palmitic acid methyl ester is a novel neuroprotective agent against cardiac arrest. Prostaglandins Leukot Essent Fatty Acids2019;
147: 6–14.
21.
LeeRHWuCYCitadinCT, et al.
Activation of neuropeptide Y2 receptor can inhibit global cerebral Ischemia-Induced brain injury. Neuromolecular Med2022;
24: 97–112.
NeumannJTCohanCHDaveKR, et al.
Global cerebral ischemia: synaptic and cognitive dysfunction. Curr Drug Targets2013;
14: 20–35.
24.
DaveKRAnthony DefazioRRavalAP, et al.
Protein kinase C epsilon activation delays neuronal depolarization during cardiac arrest in the euthermic arctic ground squirrel. J Neurochem2009;
110: 1170–1179.
25.
CoutoESAWuCYClemonsGA, et al.
Protein arginine methyltransferase 8 modulates mitochondrial bioenergetics and neuroinflammation after hypoxic stress. J Neurochem2021;
159: 742–761.
26.
AcostaCHClemonsGACitadinCT, et al.
PRMT7 can prevent neurovascular uncoupling, blood-brain barrier permeability, and mitochondrial dysfunction in repetitive and mild traumatic brain injury. Exp Neurol2023;
366: 114445.
27.
BlizardSParkDO'TooleN, et al.
Neuron-Specific IMP2 overexpression by synapsin Promoter-Driven AAV9: a tool to study its role in axon regeneration. Cells2021;
10: 2654.
28.
FinneranDJNjokuIPFlores-PazarinD, et al.
Toward development of neuron specific transduction after systemic delivery of viral vectors. Front Neurol2021;
12: 685802.
29.
McLeanJRSmithGARochaEM, et al.
Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection. Neurosci Lett2014;
576: 73–78.
30.
KuglerSKilicEBahrM.Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area. Gene Ther2003;
10: 337–347.
31.
JacksonKLDaytonRDDevermanBE, et al.
Better targeting, better efficiency for wide-scale neuronal transduction with the synapsin promoter and AAV-PHP.B. Front Mol Neurosci2016;
9: 116.
32.
HutchensMPTraystmanRJFujiyoshiT, et al.
Normothermic cardiac arrest and cardiopulmonary resuscitation: a mouse model of ischemia-reperfusion injury. Journal of Visualized Experiments: JoVE2011;
54: 3116.
33.
GracePMShimizuKStrandKA, et al.
(+)-naltrexone is neuroprotective and promotes alternative activation in the mouse hippocampus after cardiac arrest/cardiopulmonary resuscitation. Brain Behav Immun2015;
48: 115–122.
34.
WuCYCLernerFMCoutoESA, et al.
Utilizing the modified T-maze to assess functional memory outcomes after cardiac arrest. J Visual Exp: JoVE2018;
131: 56694.
35.
CohanCHNeumannJTDaveKR, et al.
Effect of cardiac arrest on cognitive impairment and hippocampal plasticity in Middle-aged rats. PloS One2015;
10: e0124918.
36.
QuillinanNDengGShimizuK, et al.
Long-term depression in Purkinje neurons is persistently impaired following cardiac arrest and cardiopulmonary resuscitation in mice. J Cereb Blood Flow Metab2017;
37: 3053–3064.
37.
DoyleMAStarkARFejes-TothG, et al.
Behavioral effects of SGK1 knockout in VTA and dopamine neurons. Sci Rep2020;
10: 14751.
38.
ClemonsGASilvaACEAcostaCH, et al.
Protein arginine methyltransferase 4 modulates nitric oxide synthase uncoupling and cerebral blood flow in Alzheimer's disease. J Cell Physiol2022. DOI: 10.1002/jcp.30858.
39.
WuCYCLopez-ToledanoMADaakAA, et al.
SC411 treatment can enhance survival in a mouse model of sickle cell disease. Prostaglandins Leukot Essent Fatty Acids2020;
158: 102110.
40.
YangLWuCLiY, et al.
Long-term exercise pre-training attenuates Alzheimer's disease-related pathology in a transgenic rat model of Alzheimer's disease. Geroscience2022;
44: 1457–1477.
41.
AcostaCHClemonsGACitadinCT, et al.
A role for protein arginine methyltransferase 7 in repetitive and mild traumatic brain injury. Neurochem Int2023;
166: 105524.
42.
MagesBFuhsTAleitheS, et al.
The cytoskeletal elements MAP2 and NF-L show substantial alterations in different stroke models while elevated serum levels highlight especially MAP2 as a sensitive biomarker in stroke patients. Mol Neurobiol2021;
58: 4051–4069.
43.
ZhanXCoxCAnderBP, et al.
Inflammation combined with ischemia produces myelin injury and Plaque-Like aggregates of myelin, amyloid-beta and AbetaPP in adult rat brain. J Alzheimers Dis2015;
46: 507–523.
44.
FowlerJHMcQueenJHollandPR, et al.
Dimethyl fumarate improves white matter function following severe hypoperfusion: involvement of microglia/macrophages and inflammatory mediators. J Cereb Blood Flow Metab2018;
38: 1354–1370.
45.
BackDBKwonKJChoiDH, et al.
Chronic cerebral hypoperfusion induces post-stroke dementia following acute ischemic stroke in rats. J Neuroinflammation2017;
14: 216.
46.
WakitaHTomimotoHAkiguchiI, et al.
A cyclooxygenase-2 inhibitor attenuates white matter damage in chronic cerebral ischemia. Neuroreport1999;
10: 1461–1465.
47.
LeeKMBangJKimBY, et al.
Fructus mume alleviates chronic cerebral hypoperfusion-induced white matter and hippocampal damage via inhibition of inflammation and downregulation of TLR4 and p38 MAPK signaling. BMC Complement Altern Med2015;
15: 125.
48.
ZlokovicBV.Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci2005;
28: 202–208.
49.
NishioKIharaMYamasakiN, et al.
A mouse model characterizing features of vascular dementia with hippocampal atrophy. Stroke2010;
41: 1278–1284.
50.
YamadaMIharaMOkamotoY, et al.
The influence of chronic cerebral hypoperfusion on cognitive function and amyloid beta metabolism in APP overexpressing mice. PloS One2011;
6: e16567.
51.
BapatALiGXiaoL, et al.
Genetic inhibition of serum glucocorticoid kinase 1 prevents obesity-related atrial fibrillation. JCI Insight2022;
7: e160885.
52.
HuangWChengCShanWS, et al.
Knockdown of SGK1 alleviates the IL-1beta-induced chondrocyte anabolic and catabolic imbalance by activating FoxO1-mediated autophagy in human chondrocytes. Febs J2020;
287: 94–107.
53.
XiXZhangJWangJ, et al.
SGK1 mediates hypoxic pulmonary hypertension through promoting macrophage infiltration and activation. Anal Cell Pathol (Amst)2019;
2019: 3013765.
54.
CordasENaray-Fejes-TothAFejes-TothG.Subcellular location of serum- and glucocorticoid-induced kinase-1 in renal and mammary epithelial cells. Am J Physiol Cell Physiol2007;
292: C1971–1981.
55.
Alvarez de la RosaDCoricTTodorovicN, et al.
Distribution and regulation of expression of serum- and glucocorticoid-induced kinase-1 in the rat kidney. J Physiol2003;
551: 455–466.
56.
MaiyarACLeongMLFirestoneGL.Importin-alpha mediates the regulated nuclear targeting of serum- and glucocorticoid-inducible protein kinase (sgk) by recognition of a nuclear localization signal in the kinase central domain. Mol Biol Cell2003;
14: 1221–1239.
57.
ParkJLeongMLBuseP, et al.
Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway. Embo J1999;
18: 3024–3033.
58.
LiYLiuCRollingL, et al.
ROS signaling-induced mitochondrial Sgk1 expression regulates epithelial cell renewal. Proc Natl Acad Sci U S A2023;
120: e2216310120.
59.
PengTIJouMJ.Oxidative stress caused by mitochondrial calcium overload. Ann N Y Acad Sci2010;
1201: 183–188.
60.
CelsiFPizzoPBriniM, et al.
Mitochondria, calcium and cell death: a deadly triad in neurodegeneration. Biochim Biophys Acta2009;
1787: 335–344.
61.
KimNChenDZhouXZ, et al.
Death-associated protein kinase 1 phosphorylation in neuronal cell death and neurodegenerative disease. Int J Mol Sci2019;
20: 3131.
62.
MouZTapperARGardnerPD.The armadillo repeat-containing protein, ARMCX3, physically and functionally interacts with the developmental regulatory factor Sox10. J Biol Chem2009;
284: 13629–13640.
63.
LaiXLiuJZouZ, et al.
SOX10 ablation severely impairs the generation of postmigratory neural crest from human pluripotent stem cells. Cell Death Dis2021;
12: 814.
64.
FinzschMStoltCCLommesP, et al.
Sox9 and Sox10 influence survival and migration of oligodendrocyte precursors in the spinal cord by regulating PDGF receptor alpha expression. Development2008;
135: 637–646.
65.
LeeJChoYOhJ, et al.
Analysis of anxiety or depression and long-term mortality among survivors of out-of-Hospital cardiac arrest. JAMA Netw Open2023;
6: e237809.
KeelerAMFlotteTR.Recombinant adeno-associated virus gene therapy in light of luxturna (and zolgensma and glybera): where are we, and how did we get here?Annu Rev Virol2019;
6: 601–621.
68.
AlkayedNJHarukuniIKimesAS, et al.
Gender-linked brain injury in experimental stroke. Stroke1998;
29: 159–165; discussion 166.
69.
MurphySMcCulloughLLittleton-KearneyM, et al.
Estrogen and selective estrogen receptor modulators: neuroprotection in the women's health initiative era. Endocrine2003;
21: 17–26.
70.
TruchKArterJTurnescuT, et al.
Analysis of the human SOX10 mutation Q377X in mice and its implications for genotype-phenotype correlation in SOX10-related human disease. Hum Mol Genet2018;
27: 1078–1092.
71.
MazuirEFrickerDSol-FoulonN.Neuron-oligodendrocyte communication in myelination of cortical GABAergic cells. Life (Basel)2021;
11: 216.
72.
PantazouVRouxTOliveira MoreiraV, et al.
Interaction between neurons and the oligodendroglial lineage in multiple sclerosis and its preclinical models. Life (Basel)2021;
11: 231.
73.
DuncanGJSimkinsTJEmeryB.Neuron-oligodendrocyte interactions in the structure and integrity of axons. Front Cell Dev Biol2021;
9: 653101.
74.
ZhangXZhangRNisa AwanMU, et al.
The mechanism and function of glia in Parkinson's disease. Front Cell Neurosci2022;
16: 903469.
75.
ZhangRChoppMZhangZG.Oligodendrogenesis after cerebral ischemia. Front Cell Neurosci2013;
7: 201.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
